Industry News
PsiMedica enters revenue sharing agreement
Perth nanotechnology company PsiVida announced that its British subsidiary PsiMedica has entered into a revenue sharing agreement with Texas Christian University (TCU) over an invention with applications in orthopaedics and tissue engineering. [ + ]
Bio Pharma signs $3.5m contract
A $3.5 million dollar conditional contract with an Asian company could give startup Bio Pharma Pty Ltd the push it needs to move into commercial production. [ + ]
Peptech reports 'outstanding' results
Biotech Peptech announced what it described as "outstanding" results from pre-clinical trials on its anti-Tumour Necrosis Factor (anti-TNF) antibody as a treatment for rheumatoid arthritis (RA). [ + ]
Oz biotechs beat the bulls
Local biotech performers have overtaken the traditional basket of stocks by 13 per cent, showing a 27 per cent leap in prices, according to a report from stockbroking firm Intersuisse. [ + ]
Imugene completes $2m placement
Veterinary biotechnology company Imugene has completed a $AUD2 million placement to institutional and professional high net worth investors. [ + ]
Bacterial proteomics attracts grant
One of the biggest ARC Linkage Project grants in the recent round has been awarded to University of Sydney microbiologist, Dr Liz Harry, to work with Australian proteomics pioneers, Proteome Systems, on bacterial proteomics. [ + ]
Link found between birth weight and kidney health
A Monash University study has found that the number of nephrons in a person's kidney increases with their birth weight, a finding that could explain why Indigenous Australians and African-Americans are at greater risk of kidney disease and high blood pressure.
[ + ]Research teams receive $73m in latest NHMRC grants
More than $AUD73 million has been awarded to 11 research teams based in Victoria, New South Wales and Queensland in the latest round of the NHMRC's program grants. [ + ]
Genetic Technologies receives $US150,000 for patent license
Texan company Inguran has paid $US150,000 to Melbourne-based Genetic Technologies to use the company's non-coding patents for genetic testing of livestock in the USA, Colombia and Brazil. [ + ]
World-class laser diagnostics facility opens in Newcastle
The official opening of a $1.5 million state-of-the-art Laser Diagnostic Laboratory took place at the University of Newcastle on Friday 13 June, advancing research into, amongst other areas, artificial heart design.
[ + ]Aussie uni establishes maternity funding for women researchers
Women academics returning from maternity leave at the University of New South Wales will be eligible for a $10,000 grant to help re-establish their careers.
[ + ]Australian Biotech Alliance formed
The competition between Victoria, NSW and Queensland over which state has the best biotechnology industry appears to have been resolved today with an agreement to form the Australian Biotech Alliance. [ + ]
Laser lab to improve artificial heart design
A $1.5million laser diagnostic laboratory could help researchers cut down thrombosis risks for artificial heart patients, using the latest Particle Image Velocimetry (PIV). [ + ]
Tissue Growth and Repair CRC backs a winner
Shooting the nag for not winning could be a thing of the past thanks to the CRC for Tissue Growth and Repair’s work on IGF-I (insulin-like growth factor-I) to stimulate tissue repair. [ + ]
Majority shareholder joins Biota board
Farooq Khan must be quietly seething. Biota has just appointed a director, Andrew Tyndale, from the ranks of new majority shareholder Babcock & Brown. [ + ]
